EIF2AK1 anticorps (N-Term)
Aperçu rapide pour EIF2AK1 anticorps (N-Term) (ABIN631998)
Antigène
Voir toutes EIF2AK1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Specificité
- EIF2 AK1 antibody was raised against the N terminal of EIF2 K1
-
Purification
- Affinity purified
-
Immunogène
- EIF2 AK1 antibody was raised using the N terminal of EIF2 K1 corresponding to a region with amino acids TCSDEFSSLRLHHNRAITHLMRSAKERVRQDPCEDISRIQKIRSREVALE
-
-
-
-
Indications d'application
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
EIF2AK1 Blocking Peptide, (ABIN5613322), is also available for use as a blocking control in assays to test for specificity of this EIF2AK1 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of EIF0 K1 antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- EIF2AK1 (Eukaryotic Translation Initiation Factor 2-alpha Kinase 1 (EIF2AK1))
-
Autre désignation
- EIF2AK1
-
Sujet
- EIF2AK1 acts at the level of translation initiation to downregulate protein synthesis in response to stress. The protein is a kinase that can be inactivated by hemin. Two transcript variants encoding different isoforms have been found for this gene.
-
Poids moléculaire
- 71 kDa (MW of target protein)
-
Pathways
- Hepatitis C
Antigène
-